Market Tracker

03/24 12:02pm ET

Impax Laboratories Inc (NASDAQ:IPXL)

9.23
Delayed Data
As of 11:47am ET
 +0.025 / +0.27%
Today’s Change
7.75
Today|||52-Week Range
37.20
-30.38%
Year-to-Date

Today’s Trading

Previous close9.20
Today’s open9.20
Day’s range9.10 - 9.38
Volume136,639
Average volume (3 months)1,681,624
Market cap$678.5M
Dividend yield--
Data as of 11:47am ET, 03/24/2017

Growth & Valuation

Earnings growth (last year)-1,327.78%
Earnings growth (this year)-29.95%
Earnings growth (next 5 years)+7.00%
Revenue growth (last year)-4.19%
P/E ratioNM
Price/Sales1.14
Price/Book1.09

Competitors

 Today’s
change
Today’s
% change
HSKAHeska Corp+0.77+0.78%
ADROAduro Biotech Inc-0.10-0.97%
TGTXTG Therapeutics Inc+0.50+4.59%
ITCIIntra-Cellular Thera...-0.03-0.20%
Data as of 12:02pm ET, 03/24/2017

Financials

Next reporting dateMay 3, 2017
EPS forecast (this quarter)$0.14
Annual revenue (last year)$824.4M
Annual profit (last year)-$472.0M
Net profit margin-57.26%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
J. Kevin Buchi
Senior Vice President-
Global Operations
Andrew Schaschl
Corporate headquarters
Hayward, California

Forecasts